STAT6 Reliably Distinguishes Solitary Fibrous Tumors from Myofibromas

被引:15
作者
Smith M.H. [1 ]
Islam N.M. [1 ]
Bhattacharyya I. [1 ]
Cohen D.M. [1 ]
Fitzpatrick S.G. [1 ]
机构
[1] Division of Oral and Maxillofacial Pathology, University of Florida College of Dentistry, 1395 Center Dr, Gainesville, 32610-0414, FL
关键词
Hemangiopericytoma; Immunohistochemistry; Myofibroma; Solitary fibrous tumor; STAT6;
D O I
10.1007/s12105-017-0836-8
中图分类号
学科分类号
摘要
Solitary fibrous tumors (SFT) and myofibromas (MF) historically have belonged to the same morphologic spectrum and have been lumped together under the nonspecific umbrella term, “hemangiopericytoma” along with other pericytic/myoid tumors. While current evidence shows clear distinction between the two entities, they frequently remain in the same histopathologic differential diagnosis. This diagnostic dilemma especially is common for smaller incisional biopsies from the oral cavity. STAT6 immunohistochemistry (IHC) recently was established as a reliable method to detect solitary fibrous tumor; however, the literature is sparse regarding STAT6 reactivity in MFs. The authors report ten new cases of oral solitary fibrous tumor, discuss histopathologic similarities and differences between the two tumors, and list respective STAT6 IHC expressivity. After IRB approval, 10 cases diagnosed as SFT and 24 cases of MF were collected from the University of Florida Oral and Maxillofacial Pathology Biopsy Service between the years 1994 and 2016. The original hematoxylin and eosin slides and related IHC were reviewed. IHC with STAT6 antibody was performed on all 34 samples, and the findings were analyzed. All cases were from the oral cavity or perioral regions. 10/10 SFTs expressed STAT6 nuclear reactivity, while no cases of MF showed nuclear expression of STAT6. STAT6 is a dependable marker to differentiate SFTs from MFs. © 2017, Springer Science+Business Media, LLC.
引用
收藏
页码:110 / 117
页数:7
相关论文
共 30 条
[1]  
Gengler C., Guillou L., Solitary fibrous tumour and haemangiopericytoma: evolution of a concept, Histopathology, 48, 1, pp. 63-74, (2006)
[2]  
Klemperer P., Rabin C.B., Primary neoplasm of the pleura: a report of 5 cases, Arch Pathol, 11, (1931)
[3]  
Stout A.P., Murray M.R., Hemangiopericytoma: a vascular tumor featuring zimmermann’s pericytes, Ann Surg, 116, 1, pp. 26-33, (1942)
[4]  
Fletcher C.D.M., Bridge J.A., Lee J.C., WHO classification of tumours of soft tissue and bone, (2013)
[5]  
Chmielecki J., Crago A.M., Rosenberg M., O'Connor R., Walker S.R., Ambrogio L., Auclair D., McKenna A., Heinrich M.C., Frank D.A., Meyerson M., Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors, Nat Genet, 45, 2, pp. 131-132, (2013)
[6]  
Mohajeri A., Tayebwa J., Collin A., Nilsson J., Magnusson L., von Steyern F.V., Brosjo O., Domanski H.A., Larsson O., Sciot R., Debiec-Rychter M., Hornick J.L., Mandahl N., Nord K.H., Mertens F., Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor, Genes Chromosomes Cancer, 52, 10, pp. 873-886, (2013)
[7]  
Robinson D.R., Wu Y.M., Kalyana-Sundaram S., Cao X., Lonigro R.J., Sung Y.S., Chen C.L., Zhang L., Wang R., Su F., Iyer M.K., Roychowdhury S., Siddiqui J., Pienta K.J., Kunju L.P., Talpaz M., Mosquera J.M., Singer S., Schuetze S.M., Antonescu C.R., Chinnaiyan A.M., Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing, Nat Genet, 45, 2, pp. 180-185, (2013)
[8]  
Demicco E.G., Harms P.W., Patel R.M., Smith S.C., Ingram D., Torres K., Carskadon S.L., Camelo-Piragua S., McHugh J.B., Siddiqui J., Palanisamy N., Lucas D.R., Lazar A.J., Wang W.L., Extensive survey of STAT6 expression in a large series of mesenchymal tumors, Am J Clin Pathol, 143, 5, pp. 672-682, (2015)
[9]  
Doyle L.A., Vivero M., Fletcher C.D., Mertens F., Hornick J.L., Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics, Mod Pathol, 27, 3, pp. 390-395, (2014)
[10]  
Hornick J.L., Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors, Mod Pathol, 27, pp. S47-S63, (2014)